Premium
Heteromeric KCNE2/KCNQ1 potassium channels in the luminal membrane of gastric parietal cells
Author(s) -
Heitzmann Dirk,
Grahammer Florian,
von Hahn Thomas,
SchmittGräff Annette,
Romeo Elisa,
Nitschke Roland,
Gerlach Uwe,
Lang Hans Jochen,
Verrey François,
Barhanin Jacques,
Warth Richard
Publication year - 2004
Publication title -
the journal of physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.802
H-Index - 240
eISSN - 1469-7793
pISSN - 0022-3751
DOI - 10.1113/jphysiol.2004.075168
Subject(s) - parietal cell , secretion , gastric acid , protein subunit , potassium channel , purinergic receptor , stimulation , chemistry , medicine , microbiology and biotechnology , endocrinology , biology , receptor , biochemistry , gene
Recently, we and others have shown that luminal K + recycling via KCNQ1 K + channels is required for gastric H + secretion. Inhibition of KCNQ1 by the chromanol 293B strongly diminished H + secretion. The present study aims at clarifying KCNQ1 subunit composition, subcellular localization, regulation and pharmacology in parietal cells. Using in situ hybridization and immunofluorescence techniques, we identified KCNE2 as the β subunit of KCNQ1 in the luminal membrane compartment of parietal cells. Expressed in COS cells, hKCNE2/hKCNQ1 channels were activated by acidic pH, PIP 2 , cAMP and purinergic receptor stimulation. Qualitatively similar results were obtained in mouse parietal cells. Confocal microscopy revealed stimulation‐induced translocation of H + ,K + ‐ATPase from tubulovesicles towards the luminal pole of parietal cells, whereas distribution of KCNQ1 K + channels did not change to the same extent. In COS cells the 293B‐related substance IKs124 blocked hKCNE2/hKCNQ1 with an IC 50 of 8 n m . Inhibition of hKCNE1‐ and hKCNE3‐containing channels was weaker with IC 50 values of 370 and 440 n m , respectively. In conclusion, KCNQ1 coassembles with KCNE2 to form acid‐activated luminal K + channels of parietal cells. KCNQ1/KCNE2 is activated during acid secretion via several pathways but probably not by targeting of the channel to the membrane. IKs124 could serve as a leading compound in the development of subunit‐specific KCNE2/KCNQ1 blockers to treat peptic ulcers.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom